Notice of Adaltis Annual Shareholders Meeting and First Quarter 2009 Results

* Reuters is not responsible for the content in this press release.

Wed Apr 29, 2009 10:39am EDT 

  MONTREAL, QUEBEC, Apr 29 (MARKET WIRE) -- 
Adaltis Inc. (TSX: ADS), an international in vitro diagnostic company,
today announced that the Company will hold its annual meeting of
shareholders on Tuesday, May 5, 2009 at 11:00 a.m. ET. The meeting will
be held at the Palais des congres de Montreal, room 513-AB, located at
159 Saint-Antoine St. West, Montreal, Quebec.

    In addition, the Company's 2009 first quarter summary results will be
released prior to the beginning of the annual shareholders meeting on May
5, 2009.

    About Adaltis

    Adaltis is an international in vitro diagnostic company with a mission to
become a leading provider of in vitro diagnostic products in emerging
markets, with a particular focus on China.

    With the strategic advantage of its "state of the art" reagent
manufacturing facility located in Shanghai, China, a complete IVD product
offering targeting emerging markets, and a strong international sales and
distribution platform, Adaltis is able to manufacture high-quality
products in a low-cost GMP environment, in order to service existing
markets in Europe, while providing a platform to penetrate the
high-growth Chinese in vitro diagnostic market.

    Adaltis is registered in Montreal, with offices in China, Italy, Mexico,
and other parts of the world.

Contacts:
Adaltis Inc.
David Gardner
Executive Vice President and Chief Financial Officer
514-335-9922, ext. 228
David.Gardner@adaltis.com

Adaltis Inc.
Peter Bambic
President and Chief Executive Officer
(8621) 5132-0898
Peter.Bambic@adaltis.com

Copyright 2009, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.